STOCK TITAN

NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

NorthShore University HealthSystem (NorthShore) and Sema4, a patient-centered health intelligence company, today announced the availability of a system-wide data-driven genomics program that utilizes predictive analytics to help clinicians and patients prevent, detect, and treat diseases at an early stage, when they are most treatable. As part of the program, NorthShore clinicians and patients will have access to Sema4’s industry-leading, information-rich genomic solutions for hereditary cancer, cardiovascular diseases, pharmacogenomics, and rare diseases.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210419005296/en/

“Unlocking the power of genomics in patient care requires us to make information available in a way that clinicians and patients can easily act upon over time,” said Peter Hulick, MD, director of the Mark R. Neaman Center for Personalized Medicine at NorthShore. “The partnership between NorthShore and Sema4 wi

CM Life Sciences Inc

NASDAQ:CMLF

CMLF Rankings

CMLF Latest News

CMLF Stock Data

Link
Finance, Financial Conglomerates

About CMLF

CM Life Sciences was founded to take advantage of a dynamic life science sector buoyed by innovation yet fragmented, where many companies are under-resourced and under-scaled. Significant and under-appreciated opportunities for consolidation are ready for engagement by a team versed in the trends and themes, and who can bring together the strongest of the new companies and management teams to capitalize on near- and far-term opportunities.